Epibiotech Co., Ltd. (XKON:446440)
19,000
+800 (4.40%)
At close: May 11, 2026
73.36% (1Y)
| Market Cap | 43.83B +69.8% |
| Revenue (ttm) | 449.62M +15.9% |
| Net Income | -5.06B |
| EPS | -2,966.00 |
| Shares Out | 2.31M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 96 |
| Average Volume | 286 |
| Open | 18,200 |
| Previous Close | 18,200 |
| Day's Range | 17,500 - 19,000 |
| 52-Week Range | 9,600 - 19,000 |
| Beta | 0.69 |
| RSI | 87.49 |
| Earnings Date | n/a |